Armata Pharmaceuticals, Inc.   Report issue

For profit Phase 2
Founded: Marina Del Rey CA United States (2005)

Organization Overview

First Clinical Trial
2020
NCT04596319
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Armata Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

ap-pa02 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Cystic Fibrosis (Phase 2)

Fibrosis (Phase 2)

Infections (Phase 2)

Pseudomonas Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1